Question explored with the scientific record
Conversation so far
- 1 Nitro 0,4 is it normal to have a headache and migraines daily and pain on shoulders + a private exchange
- 2 What if the person is on Metformin, High Cholesterol, stomach pill
Answered on this page ↓
What if the person is on Metformin, High Cholesterol, stomach pill
The short version: the retrieved evidence does not directly test whether daily nitroglycerin plus metformin, a statin, and a stomach pill causes daily headaches and shoulder pain, but it does show that nitroglycerin commonly causes headache as a side effect and that metformin interacts with many drugs through transporter competition.
The 2015 trial of transdermal nitroglycerin patches for diabetic neuropathy reported that 8 of 30 participants withdrew due to adverse effects, with headache listed as a primary cause [1]. In the 1983 angina spray study, 3 of 20 patients reported headache as an adverse effect [2]. These are consistent with nitroglycerin's known vasodilatory mechanism: it widens blood vessels, and that stretching of vessel walls is what produces headache. Daily use of a 0.4 mg dose would keep that mechanism active, making daily headaches a plausible and expected side effect.
The evidence on metformin interactions is more complex. Several studies show that other drugs can increase metformin exposure by blocking the transporters that clear it from the body. Famotidine, a stomach acid reducer, increased metformin bioavailability by 24% in healthy volunteers [5]. Oral semaglutide increased metformin AUC by 32% [4]. Ranolazine also raised metformin levels [3]. If the "stomach pill" is a proton pump inhibitor or H2 blocker, it could raise metformin levels, potentially amplifying its side effects. But none of these studies tested the combination with nitroglycerin, so the interaction profile is unknown.
Shoulder pain is not reported in any of these studies as a side effect of nitroglycerin or metformin. It could be unrelated, or it could reflect a cardiac event like angina or spasm, but the evidence here does not establish that link.
My call: daily headaches are a known and expected side effect of daily nitroglycerin use. Shoulder pain is not explained by these records. The metformin and stomach pill interactions are plausible but unstudied in this combination. Confidence: moderate for the headache link, low for the shoulder pain.
Sources used 5
-
The effect of transdermal nitroglycerin on pain control in diabetic patients with peripheral neuropathy
A randomized, double-blind, crossover trial evaluating transdermal nitroglycerin patches for pain control in adults with diabetic peripheral neuropathy showed greater pain reduction during the drug phase than placebo in the initial phase, with many withdrawals due to adverse eff…
DOI: 10.1186/s40200-015-0217-3 -
Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectoris.
A randomized, single-blind crossover trial in 20 patients with stable, exercise-induced angina shows that nitroglycerin oral spray substantially improves exercise tolerance and delays angina onset during treadmill testing, with rapid hemodynamic effects and few adverse events.
DOI: 10.1161/01.cir.67.1.124 -
Pharmacokinetic drug–drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus
This study investigates the pharmacokinetic interactions between ranolazine and metformin in subjects with type 2 diabetes mellitus, revealing that co-administration increases metformin exposure significantly, particularly at higher doses of ranolazine, without serious adverse e…
DOI: 10.1002/cpdd.174 -
Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
This study investigates the effects of oral semaglutide on the pharmacokinetics of lisinopril, warfarin, digoxin, and metformin in healthy subjects, finding no significant interactions except for a 32% increase in metformin exposure, which is not considered clinically relevant.
DOI: 10.1007/s40262-019-00756-2 -
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin
In healthy volunteers, selective inhibition of MATE1 by famotidine increased metformin bioavailability and transiently enhanced its glucose-lowering effect, while not reducing overall renal clearance and producing opposing changes in creatinine excretion/levels, highlighting com…
DOI: 10.1007/s40262-015-0346-3